Jjwb Posted April 16 Share Posted April 16 My wife was diagnosed with E-SCLC in December 2022 - about 4 cm lung tumor and some spine lesions. She started a clinical trial of carboplatin/etoposide/ atezolizumab (Tecentriq) in January, with the potential to get atezolizumab/lurbinectedin in the maintenance phase of the trial. The first part of the trial went quite well, with the primary tumor shrinking about 50% after the first two sessions, but then did not shrink further. She was randomized to atezolizumab only (no lurbinectedin) for the maintenance phase, so we are pretty sure we are going to exit the trial and start radiation together with atezolizumab (after consulting with a radiation oncologist). We would greatly appreciate any advice or experience on this course of action, and thank you for all the great content on this site! Quote Link to comment Share on other sites More sharing options...
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.